✦ LIBER ✦

Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast

✍ Scribed by X Sastre-Garau; P Genin; A Rousseau; A Al Ghuzlan; A Nicolas; P Fréneaux; C Rosty; B Sigal-Zafrani; J Couturier; J-P Thiery; H Magdelénat; A Vincent-Salomon

Book ID: 108779691
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 497 KB
Volume: 45
Category: Article
ISSN: 0309-0167
DOI: 10.1111/j.1365-2559.2004.01899.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The significance of HER-2/neu receptor p

The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease

✍ Shuko Harada; Rosemarie Mick; Robert E. Roses; Holly Graves; Huilin Niu; Anupama 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views

The effect of HER-2/neu overexpression o

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

✍ Pegram, Mark D; Finn, Richard S; Arzoo, Karo; Beryt, Malgorzata; Pietras, Richar 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 419 KB

HER2 protein overexpression in estrogen

HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy

✍ Collins, Laura C; Schnitt, Stuart J 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB

Caveolin-1 is down-regulated and inverse

Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast

✍ S-S Park; J E Kim; Y A Kim; Y C Kim; S-W Kim 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

Targeting endothelin A receptor enhances

Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

✍ Jeanett Fischgräbe; Martin Götte; Katharina Michels; Ludwig Kiesel; Pia Wülfing 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev

Increased natural killer cell activity c

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer

✍ C. Wiltschke; E. Tyl; P. Speiser; A. Steininger; R. Zeillinger; F. Kury; K. Czer 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views